White Matter Disease and Outcomes of Mechanical Thrombectomy for Acute Ischemic Stroke

References

1. 1.↵
   1. Powers WJ,
   2. Rabinstein AA,
   3. Ackerson T, et al

   ; American Heart Association Stroke Council. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018;49:e46–110 doi:10.1161/STR.0000000000000158 pmid:29367334

   Abstract/FREE Full Text
2. 2.↵
   1. Goyal M,
   2. Menon BK,
   3. van Zwam WH, et al

   ; HERMES Collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016;387:1723–31 doi:10.1016/S0140-6736(16]00163-X pmid:26898852

   CrossRefPubMed
3. 3.↵
   1. Smith EE,
   2. Saver JL,
   3. Cox M, et al

   . Increase in endovascular therapy in Get with the Guidelines-Stroke after the Publication of Pivotal Trials. Circulation 2017;136:2303–10 doi:10.1161/CIRCULATIONAHA.117.031097 pmid:28982689

   Abstract/FREE Full Text
4. 4.↵
   1. Albers GW,
   2. Marks MP,
   3. Kemp S, et al

   ; DEFUSE 3 Investigators. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018;378:708–18 doi:10.1056/NEJMoa1713973 pmid:29364767

   CrossRefPubMed
5. 5.↵
   1. Nogueira RG,
   2. Jadhav AP,
   3. Haussen DC, et al

   ; DAWN Trial Investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018;378:11–21 doi:10.1056/NEJMoa1706442 pmid:29129157

   CrossRefPubMed
6. 6.↵
   1. Roman LS,
   2. Menon BK,
   3. Blasco J, et al

   ; HERMES Collaborators. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data. Lancet Neurol 2018;17:895–904 doi:10.1016/S1474-4422(18]30242-4 pmid:30264728

   CrossRefPubMed
7. 7.↵
   The TELSA trial. Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke. https://www.cms.gov/Medicare/Coverage/IDE/Approved-IDE-Studies-Items/G190006-NCT03805308. Accessed January 31, 2020
8. 8.↵
   1. Sarraj A,
   2. Hassan AE,
   3. Savitz S, et al

   . Outcomes of endovascular thrombectomy vs medical management alone in patients with large ischemic cores: a secondary analysis of the Optimizing Patient’s Selection for Endovascular Treatment in Acute Ischemic Stroke (select) study. JAMA Neurol 2019; Jul 29. [Epub ahead of print] doi:10.1001/jamaneurol.2019.2109 pmid:31355873

   CrossRefPubMed
9. 9.↵
   1. Nagel S,
   2. Bouslama M,
   3. Krause LU, et al

   . Mechanical thrombectomy in patients with milder strokes and large vessel occlusions. Stroke 2018;49:2391–97 doi:10.1161/STROKEAHA.118.021106 pmid:30355086

   CrossRefPubMed
10. 10.↵
    1. Kongbunkiat K,
    2. Wilson D,
    3. Kasemsap N, et al

    . Leukoaraiosis, intracerebral hemorrhage, and functional outcome after acute stroke thrombolysis. Neurology 2017;88:638–45 doi:10.1212/WNL.0000000000003605 pmid:28130468

    Abstract/FREE Full Text
11. 11.↵
    1. Smith EE

    . Leukoaraiosis and stroke. Stroke 2010;41:S139–43 doi:10.1161/STROKEAHA.110.596056 pmid:20876490

    Abstract/FREE Full Text
12. 12.↵
    1. Mistry EA,
    2. Sucharew H,
    3. Mistry AM, et al

    . Blood Pressure after Endovascular Therapy for Ischemic Stroke (BEST): a multicenter prospective cohort study. Stroke 2019;50:3449–55 doi:10.1161/STROKEAHA.119.026889 pmid:31587660

    CrossRefPubMed
13. 13.↵
    1. van Swieten JC,
    2. Hijdra A,
    3. Koudstaal PJ, et al

    . Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry 1990;53:1080–83 doi:10.1136/jnnp.53.12.1080 pmid:2292703

    Abstract/FREE Full Text
14. 14.↵
    1. Boulouis G,
    2. Bricout N,
    3. Benhassen W, et al

    . White matter hyperintensity burden in patients with ischemic stroke treated with thrombectomy. Neurology 2019;93:e1498–1506 doi:10.1212/WNL.0000000000008317 pmid:31519778

    Abstract/FREE Full Text
15. 15.↵
    1. Pantoni L,
    2. Simoni M,
    3. Pracucci G, et al

    . Visual rating scales for age-related white matter changes (leukoaraiosis): can the heterogeneity be reduced? Stroke 2002;33:2827–33 doi:10.1161/01.STR.0000038424.70926.5E pmid:12468777

    Abstract/FREE Full Text
16. 16.↵
    1. Erdelyi-Botor S,
    2. Aradi M,
    3. Kamson DO, et al

    . Changes of migraine-related white matter hyperintensities after 3 years: a longitudinal MRI study. Headache 2015;55:55–70 doi:10.1111/head.12459 pmid:25319529

    CrossRefPubMed
17. 17.↵
    1. Habes M,
    2. Erus G,
    3. Toledo JB, et al

    . White matter hyperintensities and imaging patterns of brain ageing in the general population. Brain 2016;139:1164–79 doi:10.1093/brain/aww008 pmid:26912649

    CrossRefPubMed
18. 18.↵
    1. Schrag M,
    2. Kirshner H

    . Neuropsychological effects of cerebral amyloid angiopathy. Curr Neurol Neurosci Rep 2016;16:76 doi:10.1007/s11910-016-0674-1 pmid:27357378

    CrossRefPubMed
19. 19.↵
    1. Chen A,
    2. Akinyemi RO,
    3. Hase Y, et al

    . Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia. Brain 2016;139:242–58 doi:10.1093/brain/awv328 pmid:26667280

    CrossRefPubMed
20. 20.
    1. Moore EE,
    2. Hohman TJ,
    3. Badami FS, et al

    . Neurofilament relates to white matter microstructure in older adults. Neurobiol Aging 2018;70:233–41 doi:10.1016/j.neurobiolaging.2018.06.023 pmid:30036759

    CrossRefPubMed
21. 21.
    1. Osborn KE,
    2. Alverio JM,
    3. Dumitrescu L, et al

    . Adverse vascular risk relates to cerebrospinal fluid biomarker evidence of axonal injury in the presence of Alzheimer’s disease pathology. J Alzheimers Dis 2019;71:281–90 doi:10.3233/JAD-190077 pmid:31381510

    CrossRefPubMed
22. 22.↵
    1. Raz N,
    2. Yang Y,
    3. Dahle CL, et al

    . Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants. Biochim Biophys Acta 2012;1822:361–69 doi:10.1016/j.bbadis.2011.08.007 pmid:21889590

    CrossRefPubMedWeb of Science
23. 23.↵
    1. del Zoppo GJ,
    2. von Kummer R,
    3. Hamann GF

    . Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry 1998;65:1–9 doi:10.1136/jnnp.65.1.1 pmid:9667553

    FREE Full Text
24. 24.↵
    1. Henninger N,
    2. Khan MA,
    3. Zhang J, et al

    . Leukoaraiosis predicts cortical infarct volume after distal middle cerebral artery occlusion. Stroke 2014;45:689–95 doi:10.1161/STROKEAHA.113.002855 pmid:24523039

    Abstract/FREE Full Text
25. 25.↵
    1. Iwamoto T,
    2. Kubo H,
    3. Takasaki M

    . Platelet activation in the cerebral circulation in different subtypes of ischemic stroke and Binswanger’s disease. Stroke 1995;26:52–56 doi:10.1161/01.STR.26.1.52 pmid:7839397

    Abstract/FREE Full Text
26. 26.↵
    1. Inzitari D,
    2. Pracucci G,
    3. Poggesi A, et al

    ; LADIS Study Group. Changes in white matter as determinant of global functional decline in older independent outpatients: three-year follow-up of LADIS (Leukoaraiosis and Disability] study cohort. BMJ 2009;339:b2477 doi:10.1136/bmj.b2477 pmid:19581317

    Abstract/FREE Full Text
27. 27.↵
    1. Vermeer SE,
    2. Hollander M,
    3. van Dijk EJ, et al.

    , Rotterdam Scan Study. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan study. Stroke 2003;34:1126–29 doi:10.1161/01.STR.0000068408.82115.D2 pmid:12690219

    Abstract/FREE Full Text
28. 28.↵
    1. Demchuk AM,
    2. Khan F,
    3. Hill MD, et al

    ; NINDS rt-PA Stroke Study Group. Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke study. Cerebrovasc Dis 2008;26:120–25 doi:10.1159/000139658 pmid:18560214

    CrossRefPubMed
29. 29.↵
    1. Atchaneeyasakul K,
    2. Leslie-Mazwi T,
    3. Donahue K, et al

    . White matter hyperintensity volume and outcome of mechanical thrombectomy with Stentriever in acute ischemic stroke. Stroke 2017;48:2892–94 doi:10.1161/STROKEAHA.117.018653 pmid:28887393

    Abstract/FREE Full Text
30. 30.↵
    1. Guo Y,
    2. Zi W,
    3. Wan Y, et al

    . Leukoaraiosis severity and outcomes after mechanical thrombectomy with stent-retriever devices in acute ischemic stroke. J Neurointerv Surg 2019;11:137–40 doi:10.1136/neurintsurg-2018-014018 pmid:30045947

    Abstract/FREE Full Text
31. 31.
    1. Shi ZS,
    2. Loh Y,
    3. Liebeskind DS, et al

    . Leukoaraiosis predicts parenchymal hematoma after mechanical thrombectomy in acute ischemic stroke. Stroke 2012;43:1806–11 doi:10.1161/STROKEAHA.111.649152 pmid:22581819

    Abstract/FREE Full Text
32. 32.↵
    1. Zhang J,
    2. Puri AS,
    3. Khan MA, et al

    . Leukoaraiosis predicts a poor 90-day outcome after endovascular stroke therapy. AJNR Am J Neuroradiol 2014;35:2070–75 doi:10.3174/ajnr.A4029 pmid:24994827

    Abstract/FREE Full Text